Evidence map›Paper›PMID 29375303›Full record

ReviewFrontiers in molecular neuroscience2017

Fragile X Mental Retardation Protein Regulates Activity-Dependent Membrane Trafficking and

James C Sears, Kendal Broadie

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in molecular neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Developmental studies in fragile X syndrome.Journal of neurodevelopmental disorders · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

James C SearsDepartment of Biological Sciences, Vanderbilt University, Nashville, TN, United States.
Kendal BroadieDepartment of Biological Sciences, Vanderbilt University, Nashville, TN, United States.
Vanderbilt University · US

Funding

Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DYKENS, ELISABETH MAY · 2015 to 2019
$7.1M
Program in NeurogenomicsT32MH065215 · NIMH · VANDERBILT UNIVERSITY · PI ROGER J COLBRAN · 2002 to 2026
$6.4M
Genetic and Developmental Analyses of Fragile X SyndromeR01MH084989 · NIMH · VANDERBILT UNIVERSITY · PI BROADIE, KENDAL · 2009 to 2021
$5.5M
Genetic Analysis of Synapse Formation and FunctionR01MH096832 · NIMH · VANDERBILT UNIVERSITY · PI BROADIE, KENDAL · 2012 to 2016
$2.3M
Genetic and Developmental Analyses of Fragile X Mental Retardation ProteinR56MH084989 · NIMH · VANDERBILT UNIVERSITY · PI BROADIE, KENDAL · 2023 to 2023
$516k
NICHD NIH HHS U54 HD083211NIMH NIH HHS R01 MH084989NIMH NIH HHS R01 MH096832NIMH NIH HHS R56 MH084989NIMH NIH HHS T32 MH065215
6 · The paper itself

Abstract

Fragile X syndrome (FXS) is the leading monogenic cause of autism and intellectual disability. The disease arises through loss of fragile X mental retardation protein (FMRP), which normally exhibits peak expression levels in early-use critical periods, and is required for activity-dependent synaptic remodeling during this transient developmental window. FMRP canonically binds mRNA to repress protein translation, with targets that regulate cytoskeleton dynamics, membrane trafficking, and

Indexed as

critical periodDrosophilafragile X syndromesignalingsynapse

Identifiers

PMID29375303
PMCPMC5770364
OpenAlexW2784031081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.